SGD Market To Grow In Midteens For Many Years; DVOX To Be The Primary Beneficiary

Analysts at William Blair & Co initiate coverage of DynaVox Inc

with an "outperform" rating. William Blair believes that awareness of DVOX’s fully reimbursed products has increased after the acquisition of Mayer-Johnson in 2004. The “…improved programming and ease-of-use will allow the SGD market to grow in the midteens for several years, with DynaVox the primary beneficiary,” the analysts say. “Overall, the SLPs believe a meaningful number of their patients are good candidates for SGDs and that the market will continue to grow steadily in the coming quarters, with DynaVox well positioned to remain the leader… With an underpenetrated, large market opportunity likely to lead to strong top-line growth and an excellent profitability profile, we believe this valuation is compelling and that investors should begin accumulating shares,” the analysts mention.